Search results
Merck & Co. Senior Vice President and Global Franchise Head, Cardiovascular Diseases, Merck Research Laboratories (MRL), Merck & Co., Inc., Rahway, NJ. • Responsibilities: End-to-end ...
- 500+
- 778
- Cardurion Pharmaceuticals
- Greater Boston Area
From 2010 through 2013, Dr. Mendelsohn was the senior vice president and global head of cardiovascular research at Merck Research Laboratories, with overall responsibility for the scientific direction of cardiovascular research from drug discovery through late development.
Aug 3, 2017 · Cardurion was founded by two physician scientists, Daniel Bloomfield M.D. and Michael Mendelsohn M.D., who have extensive experience in cardiovascular medicine and have garnered drug discovery...
Oct 27, 2021 · The cardiovascular-focused biotech was founded by former Merck executive Michael Mendelsohn, M.D., who currently serves as chairman. CEO Peter Lawrence joined as CEO in March 2020. The...
Apr 16, 2020 · Michael Mendelsohn, founder of Cardurion and former head of cardiovascular research at Merck Research Laboratories, guided the startup to those investments in his capacity as interim CEO. But with Cardurion moving deeper into the clinic, Mendelsohn is stepping aside to let Lawrence lead.
Apr 15, 2020 · Michael Mendelsohn, founder of Cardurion and former head of cardiovascular research at Merck Research Laboratories, guided the startup to those investments in his capacity as interim CEO. But...
Michael Mendelsohn, MD, is a physician-scientist, research leader, and industry executive with broad experience in healthcare. From 2010 through 2013, Michael served as the senior vice president and head of cardiovascular research at Merck Research Laboratories, with overall responsibility for the scientific direction of cardiovascular research ...
